亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Weaponizing Immune Cells with New Liposomes to Target Metastatic Cancer

详细技术说明
Thisinvention describes a method to functionalized cells using liposomenanoparticles for inhibiting metastatic cancer cells.
*Abstract

Circulating blood cells are functionalized directly in vivo, which then adhere to circulating tumor, immune, or other cells for the treatment of metastasis, inflammation, and other conditions.

 

In one embodiment, Cornell researchers have used this approach to capture and kill circulating tumor cells (CTC) in blood and lymphatic vessels. Leukocytes were functionalized with TRAIL-decorated liposome nanoparticles. These leukocytes, bound to CTC, then induce apoptosis, thereby eliminating CTC from circulation.

Since greater than 90% of cancer related deaths are caused by metastasis, this technology offers a potentially important treatment in an area of significant and unmet need.

Additional potential applications for this approach include use of other decorated nanoparticles for various types of cancer treatment, as well as for anti-inflammatory conditions. A further utilization of this technology involves its use in imaging techniques.

 

Potential Commercial Applications:

  • Treatment for highly metastatic cancers such as breast, prostate, and lung cancer
  • Treatment for inflammation

 

Advantages

Representsa major breakthrough in cancer treatment, as there are no existing technologiesthat can both capture and kill CTC in vivo.

*Licensing
Jeff Fearnjcf55@cornell.edu607-254-4502
其他

 

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备